Related Experiment Video
Updated: Jun 18, 2026

Comprehensive Endovascular and Open Surgical Management of Cerebral Arteriovenous Malformations
Published on: October 20, 2017
Cerebral vein thrombosis
Francesco Dentali1, Walter Ageno
1Department of Clinical Medicine, Research Center on Thromboembolic Disorders and Antithrombotic Therapies, University of Insubria, Varese, Italy.
Insights
Cerebral vein thrombosis (CVT) is increasingly diagnosed, with most patients experiencing a good prognosis. Long-term anticoagulation therapy for CVT may not be necessary due to vessel recanalization and low recurrence rates.
Area of Science:
- Neurology
- Vascular Medicine
- Diagnostic Imaging
Background:
- Neuroimaging advances have improved the diagnosis and understanding of cerebral vein thrombosis (CVT).
- Evidence regarding common risk factors and the natural history of CVT is growing.
- CVT is diagnosed more frequently, necessitating updated clinical guidelines.
Purpose of the Study:
- To review current knowledge on cerebral vein thrombosis (CVT).
- To evaluate the prognosis, risk factors, and natural history of CVT.
- To assess the evidence for current therapeutic strategies in CVT management.
Main Methods:
- Review of recent literature on cerebral vein thrombosis (CVT).
- Analysis of neuroimaging findings and diagnostic trends.
- Evaluation of treatment outcomes and recurrence data.
Main Results:
- Most patients with CVT have a benign prognosis, with complete recovery or mild deficits.
- Heparin is a common first-line therapy, but evidence for its efficacy is limited.
- Vessel recanalization is common, and CVT recurrences are infrequent, questioning the need for long-term prevention.
Conclusions:
- Cerebral vein thrombosis (CVT) generally has a favorable prognosis.
- Current therapeutic approaches, including long-term anticoagulation, require further evidence-based validation.
- Routine long-term or lifelong secondary prevention for CVT may be unnecessary for most patients.
Abstract:
Advances in neuroimaging have modified our knowledge on cerebral vein thrombosis (CVT). This disease is now diagnosed more frequently, and increasing evidence as to what are the most common risk factors and on the natural history of the disease is becoming available. Most patients with CVT have a benign prognosis: only a minority of patients die during the acute phase or in the following months. Most patients surviving CVT recover completely, or have only mild functional or cognitive deficits. Unfractionated or low-molecular weight heparin is widely used as a first-line therapy of CVT, despite the absence of conclusive evidence about the safety and efficacy in this setting. Vitamin K antagonists are usually prescribed for secondary prevention, but the optimal duration of treatment remains unknown. Because most patients with CVT have partial or complete recanalization of the vessels within the first few months after the index event, and because recurrences of CVT after a first episode appear to be uncommon, routine use of long-term therapy or event life-long secondary prevention seem to be unnecessary.
Related Concept Videos
Venous Thrombosis I: Introduction
Cerebral Edema ll: Pathophysiology
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
Cerebral Edema l: Introduction